Dr. Reddy's Allots 375 Shares Under ESOPs on Sep 10, 2026
Dr. Reddy's Laboratories allotted 375 equity shares on September 10, 2026, under its ESOP scheme. The shares were exercised at Re.1/- each. Post-allotment, total issued shares are 83,46,81,285, with a total issued share capital of Rs. 83,46,81,285.
The allotment of a small number of shares (375) under an existing ESOP scheme is a routine event and is unlikely to have any material impact on the company's overall operations, financial performance, or stock price.
The announcement is a routine update regarding the allotment of shares under an employee stock option scheme and does not contain any significant financial or strategic information that would impact the company's sentiment.
Dr. Reddy's Laboratories Limited has allotted 375 equity shares of Re.1/- each, fully paid up, on September 10, 2026. This allotment was made to eligible employees pursuant to the exercise of their Stock Options under the Dr. Reddy’s Employees ADR Stock Options Scheme, 2007.
The company has provided details as required under Regulation 10(c) of the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021. The shares issued are equity shares with a par value of Re. 1/- and an exercise price of Re.1/- per share, with no premium.
Following this allotment, the total number of issued shares stands at 83,46,81,285, and the total issued share capital is Rs. 83,46,81,285/-. The newly issued shares rank pari passu with the existing shares. The ISIN number for these shares in Demat form is INE089A01031.
What to do with a filing like this
Dr. Reddy's Laboratories Limited filed this with the NSE as a statutory disclosure, categorised under others and miscellaneous. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Dr. Reddy's Laboratories Limited. Read the original for the full detail.